batabulin has been researched along with cysteine in 2 studies
| Studies (batabulin) | Trials (batabulin) | Recent Studies (post-2010) (batabulin) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
|---|---|---|---|---|---|
| 10 | 2 | 3 | 40,132 | 418 | 11,457 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckmann, H; Chou, TC; Frankmoelle, WP; Jaen, JC; Learned, RM; Medina, JC; Narbut, MR; Rosen, T; Santha, E; Shan, B; Stott, D; Timmermans, PB; Wu, P | 1 |
| Chen, L; Li, W; Li, Y; Qiu, Q; Yan, W; Yang, J; Ye, H | 1 |
2 other study(ies) available for batabulin and cysteine
| Article | Year |
|---|---|
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cysteine; Cytoskeleton; Drug Resistance, Multiple; Humans; Leukemia, Lymphoid; Mice; Mice, Nude; Microtubules; Molecular Structure; Neoplasm Transplantation; Paclitaxel; Protein Binding; Sulfonamides; Tubulin; Tumor Cells, Cultured; Vinblastine | 1999 |
Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation.
Topics: Benzamides; Cysteine; HCT116 Cells; HeLa Cells; Humans; Isothiocyanates; Protein Isoforms; Protein Multimerization; Proteolysis; Pyridines; Sulfonamides; Tubulin | 2019 |